MediPharm Labs (MEDIF)
OTHER OTC:MEDIF
Holding MEDIF?
Track your performance easily

MediPharm Labs (MEDIF) Stock Price & Analysis

406 Followers

MEDIF Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

7.02%92.26%
― Other Institutional Investors
92.26% Public Companies and
Individual Investors

MEDIF FAQ

What was MediPharm Labs’s price range in the past 12 months?
MediPharm Labs lowest stock price was $0.04 and its highest was $0.07 in the past 12 months.
    What is MediPharm Labs’s market cap?
    Currently, no data Available
    When is MediPharm Labs’s upcoming earnings report date?
    MediPharm Labs’s upcoming earnings report date is Nov 12, 2024 which is in 2 days.
      How were MediPharm Labs’s earnings last quarter?
      MediPharm Labs released its earnings results on Aug 14, 2024. The company reported -$0.007 earnings per share for the quarter, missing the consensus estimate of -$0.006 by -$0.001.
        Is MediPharm Labs overvalued?
        According to Wall Street analysts MediPharm Labs’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does MediPharm Labs pay dividends?
          MediPharm Labs does not currently pay dividends.
          What is MediPharm Labs’s EPS estimate?
          MediPharm Labs’s EPS estimate is >-$0.01.
            How many shares outstanding does MediPharm Labs have?
            MediPharm Labs has 411,070,280 shares outstanding.
              What happened to MediPharm Labs’s price movement after its last earnings report?
              MediPharm Labs reported an EPS of -$0.007 in its last earnings report, missing expectations of -$0.006. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of MediPharm Labs?
                Currently, no hedge funds are holding shares in MEDIF
                ---

                MediPharm Labs Stock Smart Score

                10
                Unlock Smart Score
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -5.76%
                12-Months-Change

                Fundamentals

                Return on Equity
                -25.11%
                Trailing 12-Months
                Asset Growth
                -21.29%
                Trailing 12-Months

                Company Description

                MediPharm Labs

                MediPharm Labs Corp has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulation without first receiving a cannabis cultivation license. The focus on cannabis concentrates from current Good Manufacturing Practices and ISO standard clean rooms and critical environments laboratory, allows MediPharm Labs to produce purified, pharmaceutical-grade cannabis oil and concentrates for derivative products. The company has invested in research-driven team, technology, downstream extraction methodologies and purpose-built facilities to deliver safe and precisely-dosed cannabis products to patients and consumers.
                ---

                MEDIF Earnings Call

                Q2 2024
                0:00 / 0:00
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Auxly Cannabis Group
                Cronos Group
                Canopy Growth
                Aurora Cannabis
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis